Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation.

Zhang, Jingyu

Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation. [electronic resource] - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Jan 2019 - 806-814 p. digital

Publication Type: Journal Article

1950-6007

10.1016/j.biopha.2018.09.086 doi


Animals
Carcinoma, Hepatocellular--drug therapy
Chalcone--analogs & derivatives
Dose-Response Relationship, Drug
Enzyme Inhibitors--pharmacology
Hep G2 Cells
Humans
Liver Neoplasms--drug therapy
Male
Mice
Neovascularization, Pathologic--drug therapy
Phosphorylation--drug effects
Pigments, Biological--pharmacology
Quinones--pharmacology
p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors